A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?
Arman ShafieeMohammad Mobin Teymouri AtharSayed-Hamidreza MozhganiPublished in: Future virology (2023)
This editorial examines what has caused the evidence around ivermectin to be so controversial, provides a brief analysis of recently published evidence, and highlights why it is important to learn lessons from ivermectin for future re-purposed drugs.